Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials.
Yousif AhmadMahesh V MadhavanGregg W StoneDarrel FrancisRaj MakkarDeepak L BhattJames P HowardPublished in: European heart journal. Quality of care & clinical outcomes (2021)
SGLT-2 inhibitors significantly reduced cardiovascular mortality and heart failure hospitalizations in patients with heart failure. The effect appears consistent across three drugs studied in four trials. SGLT-2 inhibitors should become standard care for patients with heart failure.